Skip to content
Clinical Trials – home
SlovakiaBack to Slovakia

Clinical trials in Bytca

4 clinical trials in Bytca, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.

SlovakiaOur site in SlovakiaKlinickeSkusky.sk(opens in a new tab)
Bytca at a glance
4
clinical trials
  • Recruiting now0
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

4 trials in Bytca

Open in trial search

Obesity

Not recruiting

Weight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone

InvestigationalNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Comparing weekly insulin icodec and daily insulin glargine with insulin aspart in adults with type 1 diabetes: a 26-week study of blood sugar control

Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Insulin Glargine
  • Sponsor:Novo Nordisk A/S

Type 2 diabetes mellitus+3

Not recruiting

Evaluating Once Daily Orforglipron (LY3502970) Compared to Insulin Glargine in Adults with Type 2 Diabetes and Obesity or Overweight who Have Increased Cardiovascular Risk

Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Canagliflozin
  • Sponsor:Eli Lilly & Co.

Cardiovascular disorder+1

Not recruiting

Study on the Effects of Retatrutide for Patients with Severe Obesity and Cardiovascular Disease

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:LY3437943 sodium
  • Sponsor:Eli Lilly & Co.

Other cities in Slovakia

The busiest research cities in the country

All 92 cities in Slovakia

Clinical research in Bytca

What the registry says about research in the country

01 Metabolic & Cardiovascular Research

Innovative clinical trials focusing on the intersection of obesity and cardiovascular disease, evaluating new therapeutic approaches for patients with multiple metabolic conditions.

  • Weekly Treatment Assessment
  • Cardiovascular Risk Management
  • Obesity Treatment Innovation

Studies aim to advance understanding of treatment efficacy and safety in patients with established cardiovascular conditions.

02 Diabetes & Weight Management

Comprehensive research comparing novel oral treatments with established therapies for patients with Type 2 Diabetes and weight management challenges.

  • Daily Oral Treatment Evaluation
  • Insulin Comparison Studies
  • Metabolic Health Assessment

Investigation focuses on therapeutic options for patients with multiple metabolic conditions, including diabetes and cardiovascular risk factors.

03 Integrated Health Research

Multi-faceted clinical investigations examining the relationship between chronic kidney disease, cardiovascular health, and metabolic disorders.

  • Metabolic Disease Management
  • Cardiovascular Risk Reduction
  • Combined Condition Treatment

Research explores comprehensive treatment approaches for patients with multiple health conditions requiring integrated care solutions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.